Molecular Characterization of Hepatitis C Virus for Developed Antiviral Agents Resistance Mutations and New Insights into in-silico Prediction Studies.

El-Sokkary, Mohamed M Adel; Gotina, Lizaveta; Al-Sanea, Mohammad M; Pae, Ae Nim; Elbargisy, Rehab Mohammed

El-Sokkary, Mohamed M Adel; Gotina, Lizaveta; Al-Sanea, Mohammad M; Pae, Ae Nim; Elbargisy, Rehab Mohammed.

Afiliação

El-Sokkary MMA; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
Gotina L; Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 02792, Republic of Korea.
Al-Sanea MM; Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Daejeon, Korea.
Pae AN; Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.
Elbargisy RM; Convergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 02792, Republic of Korea.

Infect Drug Resist ; 13: 4235-4248, 2020.

Article em En | MEDLINE | ID: mdl-33262618

Palavras-chave

T282S mutation; direct-acting antivirals; drug resistance; hepatitis C virus; molecular docking

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Infect Drug Resist Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google